<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="0d638967-5c49-4e6f-9f51-2258ff5099a0"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <effectiveTime value="20250515"/>
   <setId root="a1b5ccb2-d0d6-46cc-b792-6920b50d0a03"/>
   <versionNumber value="10"/>
   <author>
      <assignedEntity>
         <representedOrganization>
            <id extension="830016429" root="1.3.6.1.4.1.519.1"/>
            <name>A-S Medication Solutions</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="830016429" root="1.3.6.1.4.1.519.1"/>
                        <name>A-S Medication Solutions</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C73607" displayName="RELABEL" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="50090-3772" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="f39cf494-83a9-4eb3-840b-6acdf081fdc7"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20221122"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="50090-3772" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Nystatin</name>
                        <formCode code="C28944" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CREAM"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Nystatin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="0713-0678" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="03J11K103C" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ALGELDRATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="867H4YOZ8Z" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CETEARETH-15</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="230OU9XXE4" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GLYCERYL MONOSTEARATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="6DC9Q167V3" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PROPYLENE GLYCOL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>AQUA</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="92RU3N3Y1O" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DIMETHICONE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="506T60A25R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SORBITOL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="15FIX9V2JP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CI 77891</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="4T6H12BN9U" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PETROLATUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="A2I8C7HI9T" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>METHYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Z8IX2SC1OH" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PROPYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="B697894SGQ" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYETHYLENE GLYCOL 400</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="100000" unit="[USP'U]"/>
                              <denominator value="1" unit="g"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="BDF1O1C72E" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>NYSTATIN</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="BDF1O1C72E" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>NYSTATIN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="30" unit="g"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="50090-3772-0" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20181105"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA061966" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20150401"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value code="C48330" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="yellow" xsi:type="CE">
                              <originalText/>
                           </value>
                        </characteristic>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38304" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TOPICAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_ADF8E332-9E31-07B6-FBE4-CA6E5274ADC5">
               <id root="423ce997-dfb9-4ba7-a790-bb8474755673"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION </title>
               <text>
                  <paragraph>Nystatin is a polyene antifungal antibiotic obtained from 
       
 
  <content styleCode="italics">Streptomyces nursei</content>. 
       
 
  <br/>
                     <br/>Structural formula: 
       
 
  <br/>
                     <renderMultiMedia referencedObject="MM101"/>
                     <br/>
                     <br/>
                     <br/>
                     <content styleCode="bold"> C</content>
                     <sub>47</sub>
                     <content styleCode="bold">H</content>
                     <sub>75</sub>
                     <content styleCode="bold">NO</content>
                     <sub>17</sub>
                     <content styleCode="bold"> Molecular Weight: 926.13 </content>
                     <br/>
                     <br/>Nystatin Cream, USP is for dermatologic use.
       
 
  <br/>
                     <br/>Nystatin cream for topical use, contains 100,000 USP nystatin units per gram in a cream base containing aluminum hydroxide gel, ceteareth-15, glyceryl monostearate, polyethylene glycol 400 monostearate, propylene glycol, purified water, simethicone emulsion, sorbitol solution, titanium dioxide, white petrolatum, methylparaben, propylparaben, and sodium hydroxide.
      

 </paragraph>
               </text>
               <effectiveTime value="20221118"/>
               <component>
                  <observationMedia ID="MM101">
                     <text>image description</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="nystat-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_BAB9BD36-A59F-5F0D-CD17-F99A7FE99E47">
               <id root="d60abb81-5c72-4096-9cbc-db5bac7b7ec4"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text/>
               <effectiveTime value="20141020"/>
            </section>
         </component>
         <component>
            <section ID="ID_DECC9C49-56D4-75A3-C4DC-365852775325">
               <id root="a71d2739-474d-4b40-9cbc-2fac1a8c0dbe"/>
               <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
               <title>Pharmacokinetics</title>
               <text>
                  <paragraph>Nystatin is not absorbed from intact skin or mucous membrane.</paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_5DD22E27-177E-B3E9-9DE2-E2B2421591DE">
               <id root="45f677dd-b36a-4a99-9a7f-3288d305acf1"/>
               <code code="49489-8" codeSystem="2.16.840.1.113883.6.1" displayName="MICROBIOLOGY SECTION"/>
               <title>Microbiology</title>
               <text>
                  <paragraph>Nystatin is an antibiotic which is both fungistatic and fungicidal 
       
 
  <content styleCode="italics">in vitro</content> against a wide variety of yeasts and yeast-like fungi, including 
       
 
  <content styleCode="italics">Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes</content>. Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, 
       
 
  <content styleCode="italics">Candida albicans </content>does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of 
       
 
  <content styleCode="italics">Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) </content>become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.
      

 </paragraph>
               </text>
               <effectiveTime value="20201102"/>
            </section>
         </component>
         <component>
            <section ID="ID_98D0F21A-4D11-315C-CA14-EDE34F8B8703">
               <id root="f00c0c73-a73f-4d5a-9296-caa22464b3e4"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Nystatin Cream, USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by 
       
 
  <content styleCode="italics">Candida albicans </content>and other susceptible 
       
 
  <content styleCode="italics">Candida </content>species. 
       
 
  <br/>
                     <br/>
                     <content styleCode="bold">This cream is not indicated for systemic, oral, intravaginal or ophthalmic use.</content>
                  </paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_D8C75526-7718-2B6C-97A5-F720FAC16CE1">
               <id root="a3579cec-70f8-4ac6-8ca1-5f8b5f9a232e"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS </title>
               <text>
                  <paragraph>Nystatin cream is contraindicated in patients with a history of hypersensitivity to any of its components.</paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_D8B09E49-C472-377E-01D8-FB5803EFD6E6">
               <id root="3462b89c-974d-4a8e-8767-2bce3c3b9b78"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">General </content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Nystatin cream should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections. </content>
                     <br/>
                     <br/>If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.
      

 </paragraph>
               </text>
               <effectiveTime value="20201102"/>
            </section>
         </component>
         <component>
            <section ID="ID_2415941E-90CF-467A-E041-4D6C43AF2E10">
               <id root="60ac50c9-eecc-4ddb-b5e2-04868b985320"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>INFORMATION FOR THE PATIENT</title>
               <text>
                  <paragraph>Patients using this medication should receive the following information and instructions: 
       
 
  <br/>
                     <br/>1. The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed. 
       
 
  <br/>2. Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed. 
       
 
  <br/>3. If symptoms of irritation develop, the patient should be advised to notify the physician promptly.
      

 </paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_E1C91165-F471-1773-5CE5-29625F46D22C">
               <id root="9d099ded-6d8a-4f85-a0e4-9125514ac056"/>
               <code code="34075-2" codeSystem="2.16.840.1.113883.6.1" displayName="LABORATORY TESTS SECTION"/>
               <title>Laboratory Tests</title>
               <text>
                  <paragraph>If there is a lack of therapeutic response, KOH smears, cultures or other diagnostic methods should be repeated.</paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_E2D3E257-FCA4-1AEC-5018-F7EF15E934B8">
               <id root="a0207531-846d-4b60-9073-49e29ce53bfe"/>
               <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
               <title>Carcinogenesis, Mutagenesis, and Impairment of Fertility</title>
               <text>
                  <paragraph>No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or the effects on male or female fertility.</paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_2114E2F4-0900-B9D5-13E4-CEE9C92CB015">
               <id root="983bb084-c99e-4d70-b750-71fdd09b1151"/>
               <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
               <title>Pregnancy</title>
               <text>
                  <paragraph>Teratogenic Effects 
       
 
  <br/>
                     <br/>
                     <content styleCode="italics">Category C </content>
                     <br/>
                     <br/>Animal reproduction studies have not been conducted with any nystatin cream. It also is not known whether this cream can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin cream should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.
      

 </paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_DBCFCB90-7143-1E04-8871-6569F05A4C3C">
               <id root="1b38c360-24a1-4bfa-bbcd-f5898a750f2d"/>
               <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
               <title>Nursing Mothers</title>
               <text>
                  <paragraph>It is not known whether nystatin is excreted in human milk. Caution should be exercised when nystatin is prescribed for a nursing woman.</paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_949C6FD4-9AEE-A496-5591-743EF47BB9AF">
               <id root="8b0b4f05-d896-46a6-9781-c5290b01d2de"/>
               <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
               <title>Pediatric Use</title>
               <text>
                  <paragraph>Safety and effectiveness have been established in the pediatric population from birth to 16 years. 
       
 
  <br/>(See 
       
 
  <content styleCode="bold">
                        <linkHtml href="#ID_91D8F9A3-DF58-C71E-14E8-0E27FB420C70">DOSAGE AND ADMINISTRATION</linkHtml>
                     </content>
                     <content styleCode="bold">.</content>)
      

 </paragraph>
               </text>
               <effectiveTime value="20201102"/>
            </section>
         </component>
         <component>
            <section ID="ID_42C7B4CF-7A37-30B8-FC69-233CF2A5F01A">
               <id root="2a70d151-e24c-4344-9f0a-2123c2f2cbf7"/>
               <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
               <title>Geriatric Use</title>
               <text>
                  <paragraph>Clinical studies with nystatin cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.</paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_62EB83A3-18CA-D26E-F0E3-0B8C38B0EFAF">
               <id root="c5cb43fc-7211-4eb0-a19e-df6ffe1b66f6"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. 
       
 
  <br/>
                     <br/>(See 
       
 
  <content styleCode="bold">
                        <linkHtml href="#ID_D8B09E49-C472-377E-01D8-FB5803EFD6E6">PRECAUTIONS: General</linkHtml>
                     </content>
                     <content styleCode="bold">.</content>)
       
 
  <br/>
                     <br/>
                     <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or </content>
                     <content styleCode="bold">
                        <content styleCode="italics">
                           <linkHtml href="www.fda.gov/medwatch">www.fda.gov/medwatch</linkHtml>
                        </content>
                     </content>
                     <content styleCode="bold">.</content>
                  </paragraph>
               </text>
               <effectiveTime value="20201102"/>
            </section>
         </component>
         <component>
            <section ID="ID_91D8F9A3-DF58-C71E-14E8-0E27FB420C70">
               <id root="2a3f673c-8384-4e47-a2ab-767eab9eedbc"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">Adults and Pediatric Patients (Neonates and Older) </content>
                     <br/>
                     <br/>Apply liberally to affected areas twice daily or as indicated until healing is complete.
      

 </paragraph>
               </text>
               <effectiveTime value="20141013"/>
            </section>
         </component>
         <component>
            <section ID="ID_C2A4CE8F-B706-7C44-AAF4-512DE63A940B">
               <id root="7a121805-28a4-4d38-be73-69bc59b8a881"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Product:    50090-3772</paragraph>
                  <paragraph>NDC:    50090-3772-0   30 g in a TUBE   /  1  in a  CARTON </paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section>
               <id root="30df9653-eb1e-4d67-88ce-41ba3ca2a30d"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Nystatin Cream</title>
               <text>
                  <renderMultiMedia referencedObject="lbl500903772"/>
               </text>
               <effectiveTime value="20250515"/>
               <component>
                  <observationMedia ID="lbl500903772">
                     <text>Label Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="lbl500903772.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>